Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Can Jack Daniel’s distiller Brown-Forman shake off its nasty hangover?

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Investor expectations are depressed ahead of first quarter results (29 August) from Jack Daniel’s distiller Brown-Forman (BF.B:NYSE) given the difficult market conditions facing the Lawson Whiting-led group and peers ranging from Diageo (DGE) and Pernod Ricard (RI:EPA) to Remy Cointreau (RCO:EPA).
Growth is slowing in the global spirits industry following the strength seen during and immediately after the Covid pandemic, and while Brown-Forman is making progress internationally it remains heavily skewed toward the sluggish US spirits market.
Shares in Brown-Forman, which has had to cut its organic growth forecast on a number of occasions of late, are nursing a heavy hangover as a result, down 35% over one year and more than 20% lower on a five-year view.
On 5 June, the Louisville-based company, whose brands also include Diplomatico rum, Woodford Reserve bourbon and Fords Gin, poured out news of a disappointing 8% decrease in net sales to $1 billion for the fourth quarter ended 30 April 2024.
Encouragingly, Brown-Forman said it expected a return to growth for organic sales and organic operating income for the year to April 2025 driven by ‘gains in international markets and the benefit of normalising inventory trends’, although this outlook was tempered by a belief that ‘global macroeconomic and geopolitical uncertainties will continue to create a challenging operating environment’.
US UPDATES OVER THE NEXT 7 DAYS
QUARTERLY RESULTS
27 Aug: GE Healthcare, Hewlett Packard
28 Aug: Nvidia, Salesforce, CrowdStrike Holdings, HP Inc, NetApp, Cooper, JM Smucker, Bath & Body Works
29 Aug: Marvell, Dollar General, Brown Forman, Best Buy, MongoDB, Ulta Beauty, Campbell Soup
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.